Phase I trial of ZD9331, a non-polyglutamatable thymidylate synthase inhibitor given as a 5-day continuous infusion every 3 weeks - Concepedia

Concepedia

Publication | Closed Access

Phase I trial of ZD9331, a non-polyglutamatable thymidylate synthase inhibitor given as a 5-day continuous infusion every 3 weeks

12

Citations

0

References

1999

Year

José Trigo, Clarence E. Rees, Philip Beale, F. Mitchell, A.L. Jackman, Rhodri Smith, Michael G. Hutchison, M. Katharine Smith, I. Judson

European Journal of Cancer

MedicineClinical TrialsBiomolecular EngineeringPharmacologyNovel Therapy5-Day Continuous InfusionDrug Discovery

No additional data available for this publication yet. Check back later!